Kopran share news, announcements and annual reports
NSE: KOPRANBSE: 524280Pharmaceuticals & BiotechnologySmall Cap
Kopran Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Mar 1993 on BSE, Jun 1999 on NSE
Last close ₹242.21up ₹3.16 (1.32%)BSE ₹242.10
Share price at the NSE close on 2 Nov 2026. Previous close ₹239.05.
2 Nov: open ₹240.50, high ₹246.27, low ₹239.00
52-week range of traded prices to 2 Nov 2026
₹107.00Low, 30 Mar 2026₹295.83High, 30 Sep 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,171 Cr1,663rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 46.85
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.21
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.24%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 4.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 6.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.29
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,22,395
Kopran board meetings
112 filed, newest first. Page 2 of 3.
May 2018
Jan 2018
Nov 2017
Aug 2017
4 Aug · Board meeting
Apr 2017
Jan 2017
Nov 2016
14 Nov · Board meeting
Oct 2016
Jul 2016
Apr 2016
Jan 2016
Oct 2015
Jul 2015
May 2015
14 May · Board meeting
To consider inter alia a) Audited Financial Results of the Company for the Fourth Quarter ended on March 31, 2015; b) Audited standalone & consolidated financial results for twelve months financial year ended on March 31, 2015.
Feb 2015
2 Feb · Board meeting
To consider and approve 3rd Quarter Results ended December 31, 2014.
Oct 2014
29 Oct · Board meeting
To consider and approve Unaudited Financial Results for the Quarter ended September 30, 2014.
Sep 2014
29 Sep · Board meeting
29 Sep · Board meeting
To consider, subject to approval of shareholders by way Postal Ballot among other items: (1) To consider issue of Equity Shares and/ or Warrants on Preferential basis to Promoter Group. (2) To consider Slump Sales of Active Pharmaceutical Ingredients (API) business to its Subsidiary Company, Kopran Research Laboratories Limited.
Aug 2014
5 Aug · Board meeting
To consider and approve Unaudited Financial Results for the Quarter Ended June 30, 2014. Further, it is informed that, the Trading Window will be closed from August 07, 2014 to August 14, 2014 as per the code of Internal Procedure and Conduct for Prevention of Insider Trading adopted by the Company.
May 2014
29 May · Board meeting
Board of Directors of the Company at its meeting held on May 28, 2014, has approved the following: 1. Resignation of Mr. Abhinav Mathur as a Company Secretary & Compliance Officer of the Company was accepted by the Board of Directors of the Company. 2. Appointment of Mr. Sunil Sodhani as a Company Secretary & Compliance Officer of the Company was approved by the Board of Directors of the Company.
Feb 2014
4 Feb · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended December 31, 2013. Further, the Trading Window will be closed for a period of 7 days i.e. From February 07, 2014 to February 14, 2014 as per the code of Internet Procedure and Conduct for Prevention of Insider Trading adopted by the Company.
Nov 2013
15 Nov · Board meeting
Board of Directors of the Company at its meeting held on November 13, 2013, has approved the following: Renewal of the appointment of Mr. Surendra Somani as Executive Vice Chairman of the Company for further period of 5 years w.e.f. January 01, 2014.
Oct 2013
28 Oct · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended September 30, 2013.
Jul 2013
31 Jul · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended June 30, 2013.
May 2013
20 May · Board meeting
To consider and take on record Audited Financial Results for the Year ended March 31, 2013.
Feb 2013
1 Feb · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended December 31, 2012.
Oct 2012
29 Oct · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended September 30, 2012.
Aug 2012
2 Aug · Board meeting
To consider and take on record Unaudited Financial Results for the quarter ended June 30, 2012.
Jul 2012
5 Jul · Board meeting
Company had informed the Exchange that a meeting of the Board of Directors of the Company will be held on July 12, 2012 to consider and take on record Audited Financial Results for the year Ended March 31, 2012. The Company has now informed the Exchange that the aforesaid Board Meeting has been rescheduled and will now be held on July 13, 2012.Not held on this date
4 Jul · Board meeting
To consider and take on record Audited Financial Results for the year Ended March 31, 2012.
May 2012
7 May · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter Ended March 31, 2012.
Feb 2012
2 Feb · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter ended December 31, 2011.
Nov 2011
2 Nov · Board meeting
To consider and take on record Inaudited Financial Results for the Quarter Ended September 30, 2011.
Jul 2011
22 Jul · Board meeting
To consider and take on record Audited Financial Results for the Year Ended March 31, 2011 and Unaudited Financial Results for the Quarter Ended June 30, 2011.
May 2011
6 May · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter ended March 31, 2011.
Feb 2011
3 Feb · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter ended December 31, 2010.
Nov 2010
3 Nov · Board meeting
To consider and take on record Unaudited Financial Results for the Quarter ended September 30, 2010.
Jul 2010
28 Jul · Board meeting
To consider and take on record Audited Financial Results for the year ended March 31, 2010 and Unaudited Financial Results for the Quarter ended June 30, 2010.
May 2010
11 May · Board meeting
Company would publish un-audited financial results within 45 days from the end of the last quarter and the meeting of the Board of Directors is scheduled to be held on May 14, 2010.
Jan 2010
19 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
22 Oct · Board meeting
Meeting on 31 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Jul 2009
22 Jul · Board meeting
Meeting on 29 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”2 Jul · Board meeting
Kopran Ltd. has informed the Exchange that the Board of Directors of the Company at their meeting held on June 30, 2009 has decided to issue on Preferential basis 19,50,000 Warrants and 18,50,000 equity shares of Rs.10/- each to the Promoters / Associates at a price arrived at as per SEBI Guidelines.
Jun 2009
15 Jun · Board meeting
To consider and approve Audited Financial Results for the Year Ended March 31, 2009.
Jan 2009
21 Jan · Board meeting
Meeting on 30 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
18 Oct · Board meeting
Meeting on 25 Oct 2008: “Unaudited financial results for qtr ended September 30, 2008”
Jul 2008
23 Jul · Board meeting
Meeting on 30 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”